Terms: = Head and neck cancer AND CSF3R, CD114, 1441, ENSG00000119535, GCSFR AND Treatment
8 results:
1. A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with head and neck cancer Negative for HPV Infection.
Hess J; Unger K; Maihoefer C; Schüttrumpf L; Wintergerst L; Heider T; Weber P; Marschner S; Braselmann H; Samaga D; Kuger S; Pflugradt U; Baumeister P; Walch A; Woischke C; Kirchner T; Werner M; Werner K; Baumann M; Budach V; Combs SE; Debus J; Grosu AL; Krause M; Linge A; Rödel C; Stuschke M; Zips D; Zitzelsberger H; Ganswindt U; Henke M; Belka C
Clin Cancer Res; 2019 Mar; 25(5):1505-1516. PubMed ID: 30171046
[TBL] [Abstract] [Full Text] [Related]
2. cancer of the head and neck: a set of indicators based on register and administrative data.
Andreano A; Ansarin M; Alterio D; Bruschini R; Valsecchi MG; Russo AG
Acta Otorhinolaryngol Ital; 2018 Feb; 38(1):13-23. PubMed ID: 29756612
[TBL] [Abstract] [Full Text] [Related]
3. IAPs cause resistance to TRAIL-dependent apoptosis in follicular thyroid cancer.
Werner TA; Nolten I; Dizdar L; Riemer JC; Schütte SC; Verde PE; Raba K; Schott M; Knoefel WT; Krieg A
Endocr Relat Cancer; 2018 Mar; 25(3):295-308. PubMed ID: 29317481
[TBL] [Abstract] [Full Text] [Related]
4. Gefitinib single drug in treatment of advanced esophageal cancer.
Xu Y; Xie Z; Shi Y; Zhang M; Pan J; Li Y; Lu H
J Cancer Res Ther; 2016 Dec; 12(Supplement):C295-C297. PubMed ID: 28230041
[TBL] [Abstract] [Full Text] [Related]
5. Experience of multidisciplinary assessment of elderly patients with cancer in a French general hospital during 1 year: a new model care study.
Bouzereau V; Le Caer F; Guardiola E; Scavennec C; Barriere JR; Chaix L; Le Caer H
J Geriatr Oncol; 2013 Oct; 4(4):394-401. PubMed ID: 24472485
[TBL] [Abstract] [Full Text] [Related]
6. Granulocyte colony-stimulating factor (G-CSF)-mediated signaling regulates type IV collagenase activity in head and neck cancer cells.
Sugimoto C; Fujieda S; Sunaga H; Noda I; Tanaka N; Kimura Y; Saito H; Matsukawa S
Int J Cancer; 2001 Jul; 93(1):42-6. PubMed ID: 11391619
[TBL] [Abstract] [Full Text] [Related]
7. Granulocyte-colony-stimulating factor enhances invasive potential of human head-and-neck-carcinoma cell lines.
Noda I; Fujieda S; Ohtsubo T; Tsuzuki H; Tanaka N; Sunaga H; Saito H
Int J Cancer; 1999 Jan; 80(1):78-84. PubMed ID: 9935235
[TBL] [Abstract] [Full Text] [Related]
8. Expression of granulocyte colony-stimulating factor receptor correlates with prognosis in oral and mesopharyngeal carcinoma.
Tsuzuki H; Fujieda S; Sunaga H; Noda I; Saito H
Cancer Res; 1998 Feb; 58(4):794-800. PubMed ID: 9485037
[TBL] [Abstract] [Full Text] [Related]
